Central Serous Chorioretinopathy after Local Application of Glucocorticoids for Skin Disorders

Archives of Ophthalmology

Volumn 122, Issue 5, 2004, Pages 784-786

  Karadimas, Panagiotis ^a,b   Kapetanios, Anastasios ^a   Bouzas, Evrydiki A ^a  

^a Henry Dunant Hospital ^*

^b HENRY DUNANT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DIFLUCORTOLONE VALERATE; GLUCOCORTICOID; ISOCONAZOLE;

ADULT; ARTICLE; CASE REPORT; CENTRAL SEROUS RETINOPATHY; CLINICAL FEATURE; DISEASE COURSE; DRUG INDUCED DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SKIN DISEASE; TINEA VERSICOLOR; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ADULT; CHOROID DISEASES; DERMATITIS, SEBORRHEIC; DIFLUCORTOLONE; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; MALE; RETINAL DISEASES; TINEA VERSICOLOR; VISUAL ACUITY;

EID: 2342615459     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.5.784     Document Type: Article

References (5)

1. Bouzas EA, Scott MH, Mastorakos G, Chrousos GP, Kaiser-Kupfer MI. Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol. 1993;111:1229-1233.
2. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47:431-448.
3. Aalto-Korte K, Turpeinen M. Pharmacokinetics of topical hydrocortisone at plasma level after applications once or twice daily in patients with widespread dermatitis. Br J Dermatol. 1995;133:259-263.
4. Cook LJ, Freinkel RK, Zugerman C, Levin DL, Radtke R. Iatrogenic hyperadrenocorticism during topical steroid therapy: assessment of systemic effects by metabolic criteria. J Am Acad Dermatol. 1982;6:1054-1060.
5. Garden JM, Freinkel RK. Systemic absorption of topical steroids: metabolic effects as an index of mild hypercortisolism. Arch Dermatol. 1986;122:1007-1010.